Pathogenesis of diabetic retinopathyENGERMAN, R. L.Diabetes (New York, NY). 1989, Vol 38, Num 10, pp 1203-1206, issn 0012-1797Article

Aldose reductase and the development of renal disease in diabetic dogsKERN, T. S; ENGERMAN, R. L.Journal of diabetes and its complications. 1999, Vol 13, Num 1, pp 10-16, issn 1056-8727Article

Galactose-induced retinal microangiopathy in ratsKERN, T. S; ENGERMAN, R. L.Investigative ophthalmology & visual science. 1995, Vol 36, Num 2, pp 490-496, issn 0146-0404Article

Retinal polyol and myo-inositol in galactosemic dogs given an aldose-reductase inhibitorKERN, T. S; ENGERMAN, R. L.Investigative ophthalmology & visual science. 1991, Vol 32, Num 13, pp 3175-3177, issn 0146-0404Article

Progression of incipient diabetic retinopathy during good glycemic controlENGERMAN, R. L; KERN, T. S.Diabetes (New York, NY). 1987, Vol 36, Num 7, pp 808-812, issn 0012-1797Article

Microvascular metabolism in diabetesKERN, T. S; ENGERMAN, R. L.Metabolism, clinical and experimental. 1986, Vol 35, Num 4, pp 24-27, issn 0026-0495, suppl. 1Conference Paper

A mouse model of diabetic retinopathyKERN, T. S; ENGERMAN, R. L.Archives of ophthalmology (1960). 1996, Vol 114, Num 8, pp 986-990, issn 0003-9950Article

Experimental galactosemia produces diabetic-like retinopathyENGERMAN, R. L; KERN, T. S.Diabetes (New York, NY). 1984, Vol 33, Num 1, pp 97-100, issn 0012-1797Article

Abnormal amino acid concentrations in plasma and urine of experimentally diabetic dogsKERN, T. S; ENGERMAN, R. L.Research in experimental medicine. 1983, Vol 182, Num 3, pp 185-192, issn 0300-9130Article

Aldose reductase inhibition fails to prevent retinopathy in diabetic and galactosemic dogsENGERMAN, R. L; KERN, T. S.Diabetes (New York, NY). 1993, Vol 42, Num 6, pp 820-825, issn 0012-1797Article

Urinary protein excretion rates in experimentally diabetic dogs and experimentally galactosaemic dogsKERN, T. S; ENGERMAN, R. L.Diabetologia (Berlin). 1988, Vol 31, Num 12, pp 928-932, issn 0012-186XArticle

Capillary lesions develop in retina rather than cerebral cortex in diabetes and experimental galactosemiaKERN, T. S; ENGERMAN, R. L.Archives of ophthalmology (1960). 1996, Vol 114, Num 3, pp 306-310, issn 0003-9950Article

Retinopathy in galactosemic dogs continues to progress after cessation of galactosemiaENGERMAN, R. L; KERN, T. S.Archives of ophthalmology (1960). 1995, Vol 113, Num 3, pp 355-358, issn 0003-9950Article

Renal hemodynamics in experimentally galactosemic dogs and diabetic dogsKERN, T. S; ENGERMAN, R. L.Metabolism, clinical and experimental. 1991, Vol 40, Num 5, pp 450-454, issn 0026-0495Article

Hyperglycemia and development of glomerular pathology: diabetes compared with galactosemiaENGERMAN, R. L; KERN, T. S.Kidney international. 1989, Vol 36, Num 1, pp 41-45, issn 0085-2538Article

Retinopathy in animal models of diabetesENGERMAN, R. L; KERN, T. S.Diabetes/metabolism reviews. 1995, Vol 11, Num 2, pp 109-120, issn 0742-4221Article

Vascular lesions in diabetes are distributed non-uniformly within the retinaKERN, T. S; ENGERMAN, R. L.Experimental eye research. 1995, Vol 60, Num 5, pp 545-549, issn 0014-4835Article

Arrest of glomerulopathy in diabetic dogs by improved glycaemic controlKERN, T. S; ENGERMAN, R. L.Diabetologia (Berlin). 1990, Vol 33, Num 9, pp 522-525, issn 0012-186XArticle

Kidney morphology in experimental hyperglycemiaKERN, T. S; ENGERMAN, R. L.Diabetes (New York, NY). 1987, Vol 36, Num 2, pp 244-249, issn 0012-1797Article

Hyperglycemia as a cause of diabetic retinopathyENGERMAN, R. L; KERN, T. S.Metabolism, clinical and experimental. 1986, Vol 35, Num 4, pp 20-23, issn 0026-0495, suppl. 1Conference Paper

Hexitol production by canine retinal microvesselsKERN, T. S; ENGERMAN, R. L.Investigative ophthalmology & visual science. 1985, Vol 26, Num 3, pp 382-384, issn 0146-0404Article

Platelet aggregation in experimental diabetes and experimental galactosemiaKERN, T. S; ENGERMAN, R. L.Diabetes (New York, NY). 1984, Vol 33, Num 9, pp 846-850, issn 0012-1797Article

Comparison of DNA breaks in diabetic dogs and galactosemic dogs developing retinopathyKERN, T. S; ENGERMAN, R. L.Current eye research (Print). 1989, Vol 8, Num 8, pp 765-769, issn 0271-3683Article

Is diabetic retinopathy preventable?ENGERMAN, R. L; KERN, T. S.International ophthalmology clinics. 1987, Vol 27, Num 4, pp 225-229, issn 0020-8167Article

Abnormalities of retinal metabolism in diabetes or galactosemia : ATPases and glutathioneKERN, T. S; KOWLURU, R. A; ENGERMAN, R. L et al.Investigative ophthalmology & visual science. 1994, Vol 35, Num 7, pp 2962-2967, issn 0146-0404Article